Global Synthetic Biology Market Trends and Outlook
Synthetic biology is an interdisciplinary field that combines biology, engineering, systems biology, bioinformatics, chemistry, mathematics, and computer science to design and construct new biological systems or enhance existing ones for specific applications. The field has evolved rapidly from its conceptual foundations in genome engineering to become a transformative platform technology supporting innovation across healthcare, industrial manufacturing, agriculture, environmental sustainability, and advanced materials. The growing ability to engineer biological functions with greater precision, coupled with advances in DNA synthesis, genome editing, sequencing technologies, and computational biology, continues to expand the commercial potential of synthetic biology worldwide.
The global Synthetic Biology market was valued at US$26.6 billion in 2025 and is projected to reach US$99.4 billion by 2032, registering a CAGR of 20.7% during the forecast period. Market growth is being driven by increasing investments in biotechnology research, rising demand for synthetic DNA and engineered biological systems, expanding applications in therapeutics and industrial biotechnology, and continued advancements in genome engineering and biological components. Strong commercialization activity, growing venture capital investments, and increasing adoption of synthetic biology solutions for sustainable production, environmental management, and next-generation healthcare applications are expected to support robust market expansion through 2032.
Synthetic Biology Regional Market Analysis
North America accounted for the largest share of the Synthetic Biology market in 2025, valued at US$8.9 billion and representing 33.5% of the global market, supported by extensive biotechnology research activities, strong commercialization capabilities, and continued investments in synthetic biology innovation. Europe ranked as the second-largest regional market, remaining closely aligned with North America due to its well-established life sciences sector and growing adoption of advanced biological engineering technologies. Asia-Pacific is projected to be the fastest-growing regional market through 2032, registering a CAGR of 23.2%. The rapid expansion across Asia-Pacific is expected to increase its market share to 24.5% by 2032, reflecting accelerating investments in biotechnology infrastructure, research capabilities, and industrial-scale synthetic biology applications across emerging markets.
Synthetic Biology Market Analysis by Product Type
Oligonucleotides represented the largest product type segment in the Synthetic Biology market in 2025, accounting for 41% of total market revenue, driven by their critical role in gene synthesis, genome editing, molecular diagnostics, and therapeutic development. Enzymes ranked as the second-largest segment, closely followed by Chassis Organism, reflecting growing demand for engineered biological systems and microbial platforms. Chassis Organism is projected to be the fastest-growing product category during 2025-2032, registering a CAGR of 22.3%, supported by increasing applications in industrial biotechnology, sustainable manufacturing, and synthetic biology research.
Synthetic Biology Market Analysis by Technology
Genome Engineering dominated the Synthetic Biology market by technology in 2025, generating US$11.3 billion, supported by its extensive use in gene editing, metabolic engineering, and development of advanced therapeutic and industrial biological solutions. DNA Sequencing remained the second-largest technology segment. Biological Components & Integrated Systems segment is projected to be the fastest-growing technology segment through 2032, registering a CAGR of 22.9%, driven by increasing adoption of engineered biological circuits, integrated cellular systems, and automated bio-manufacturing platforms.
Synthetic Biology Market Analysis by Application
Medical applications held the largest share of the Synthetic Biology market in 2025, accounting for 35.2% of total market revenue, driven by growing use of synthetic biology in drug discovery, gene therapies, diagnostics, and precision medicine. Industrial applications closely followed with a market value of US$9.1 billion, making it the second-largest segment and highlighting the expanding adoption of engineered biological systems in biofuels, specialty chemicals, and sustainable manufacturing processes. Environmental applications are projected to be the fastest-growing application segment through 2032, registering a CAGR of 22.7%, supported by increasing focus on bioremediation, waste management, carbon reduction, and environmental sustainability initiatives.
Synthetic Biology Market Report Scope
This global report on Synthetic Biology analyzes the market based on product type, technology and application for the period 2022-2032 with projections from 2025 to 2032 in terms of value in US$. In addition to providing profiles of major companies operating in the Synthetic Biology industry, the latest corporate, product and industrial developments have been covered to offer a clear panorama of Synthetic Biology industry.
Key Metrics
| Historical Period: | 2022-2025 | |
| Base Year: | 2025 | |
| Forecast Period: | 2025-2032 | |
| Units: | Value market in US$ | |
| Companies Mentioned: | 30+ |
Global Synthetic Biology Market by Geographic Region
- North America (The United States, Canada and Mexico)
- Europe (The United Kingdom, Germany, France, Italy, Spain and Rest of Europe)
- Asia-Pacific (Japan, China, Australia, India and Rest of Asia-Pacific)
- Rest of World (Brazil, Israel and Other ROW)
Global Synthetic Biology Market by Product Type
- Oligonucleotides
- Enzymes
- Chassis Organism
- Others
Global Synthetic Biology Market by Technology
- Genome Engineering
- DNA Sequencing
- Biological Components & Integrated Systems
- Others
Global Synthetic Biology Market by Application
- Medical
- Industrial
- Environmental
- Others
Synthetic Biology Market Frequently Asked Questions (FAQs)
The Synthetic Biology market is projected to reach US$99.4 billion by 2032, growing from US$26.6 billion in 2025 at a CAGR of 20.7%.
Key growth drivers include advances in genome engineering, increasing use of synthetic DNA, rising biotechnology investments, expanding medical applications, and growing demand for sustainable industrial production methods.
Oligonucleotides represent the largest product segment, accounting for 41% of market revenue in 2025 due to their broad use in gene synthesis, diagnostics, and therapeutic development.
Genome Engineering is the leading technology segment, holding a 42.7% market share in 2025, supported by increasing adoption of gene editing and biological engineering technologies.
Medical applications lead the market with a 35.2% share in 2025, driven by demand for synthetic biology solutions in drug discovery, diagnostics, gene therapy, and precision medicine.
Asia-Pacific is projected to be the fastest-growing regional market through 2032, supported by rising investments in biotechnology infrastructure, research capabilities, and commercialization activities.
The report provides detailed analysis of product types, technologies, applications, regional markets, competitive landscape, company profiles, market forecasts, growth opportunities, and industry developments covering the period from 2022 through 2032.
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Product Outline
- Synthetic Biology – Objectives
- Dissimilarities between the Synthetic Biology and System Biology
- Synthetic Biology – An Evolution
- Dissimilarities between Synthetic Biology and Genetic Engineering
- Synthetic Biology Product Types
- Oligonucleotides
- Enzymes
- Chassis Organism
- Xeno Nucleic Acids
- Cloning Technology Kits
- Technologies of Synthetic Biology
- Genome Engineering
- DNA Sequencing
- Biological Components and Integrated Systems
- Pathway Engineering
- Bioinformatics
- Microfluidics
- Synthetic Biology Applications
- Medical
- Drug Discovery
- Vaccines – Disease Avoidance
- Cancer treatment
- Industrial
- Biofuels
- Bioplastics
- Bio Isoprene
- 1,3-propanediol (1.3-PDO)
- Environmental
- Agriculture
- Production of Plants Tolerable to Abiotic Stress and Drought
- Minimal usage of fertilizers and Pesticides
- Disease Tolerance Plants
- Molecular Farming
- Promoter Micro Organisms for Deep Space Operations
- Bio-based Production for In-space Development
- Synthetic Biology for Biomaterial Generation
- Food
- Cement Production
- Silk Thread Fabrication
2. KEY MARKET TRENDS
3. KEY GLOBAL PLAYERS
- Amyris, Inc. (United States)
- ATUM (United States)
- Centrient Pharmaceuticals (Singapore)
- Chevron (Renewable Energy Group, Inc.) (United States)
- Codexis, Inc. (Untied States)
- EvoNext Holdings SA (Switzerland)
- GENEWIZ, Inc (United States)
- Genscript Corporation (United States)
- Ginkgo Bioworks, Inc. (United States)
- Green Biologics Ltd. (The United Kingdom)
- Integrated DNA Technologies, Inc. (United States)
- International Flavors & Fragrances (IFF) (United States)
- LC Sciences LLC (United States)
- Millipore Sigma (Untied States)
- Novonesis Group (Denmark)
- Precigen, Inc. (United States)
- Theriva Biologics, Inc. (United States)
- Thermo Fisher Scientific, Inc. (United States)
4. KEY BUSINESS TRENDS
5. GLOBAL MARKET OVERVIEW
- Global Synthetic Biology Market Overview by Product Type
- Global Synthetic Biology Product Type Market Overview by Geographic Region
- Oligonucleotides
- Enzymes
- Chassis Organism
- Other Product Types
- Global Synthetic Biology Market Overview by Technology
- Global Synthetic Biology Technology Market Overview by Geographic Region
- Genome Engineering
- DNA Sequencing
- Biological Components and Integrated Systems
- Other Technologies for Synthetic Biology
- Global Synthetic Biology Market Overview by Application
- Global Synthetic Biology Application Market Overview by Geographic Region
- Medical Applications
- Industrial Applications
- Environmental Applications
- Other Applications
PART B: REGIONAL MARKET PERSPECTIVE
REGIONAL MARKET OVERVIEW
6. NORTH AMERICA
- North American Synthetic Biology Market Overview by Geographic Region
- North American Synthetic Biology Market Overview by Product Type
- North American Synthetic Biology Market Overview by Technology
- North American Synthetic Biology Market Overview by Application
- Country-wise Analysis of North American Synthetic Biology Market
- The United States
- United States Market Overview by Product Type
- United States Market Overview by Technology
- United States Market Overview by Application
- Canada
- Canadian Market Overview by Product Type
- Canadian Market Overview by Technology
- Canadian Market Overview by Application
- Mexico
- Mexican Market Overview by Product Type
- Mexican Market Overview by Technology
- Mexican Market Overview by Application
7. EUROPE
- European Synthetic Biology Market Overview by Geographic Region
- European Synthetic Biology Market Overview by Product Type
- European Synthetic Biology Market Overview by Technology
- European Synthetic Biology Market Overview by Application
- Country-wise Analysis of European Synthetic Biology Market
- The United Kingdom
- United Kingdom Market Overview by Product Type
- United Kingdom Market Overview by Technology
- United Kingdom Market Overview by Application
- Germany
- German Market Overview by Product Type
- German Market Overview by Technology
- German Market Overview by Application
- France
- French Market Overview by Product Type
- French Market Overview by Technology
- French Market Overview by Application
- Italy
- Italian Market Overview by Product Type
- Italian Market Overview by Technology
- Italian Market Overview by Application
- Spain
- Spanish Market Overview by Product Type
- Spanish Market Overview by Technology
- Spanish Market Overview by Application
- Rest of Europe
- Rest of Europe Market Overview by Product Type
- Rest of Europe Market Overview by Technology
- Rest of Europe Market Overview by Application
8. ASIA-PACIFIC
- Asia-Pacific Synthetic Biology Market Overview by Geographic Region
- Asia-Pacific Synthetic Biology Market Overview by Product Type
- Asia-Pacific Synthetic Biology Market Overview by Technology
- Asia-Pacific Synthetic Biology Market Overview by Application
- Country-wise Analysis of Asia-Pacific Synthetic Biology Market
- Japan
- Japanese Market Overview by Product Type
- Japanese Market Overview by Technology
- Japanese Market Overview by Application
- China
- Chinese Market Overview by Product Type
- Chinese Market Overview by Technology
- Chinese Market Overview by Application
- Australia
- Australian Market Overview by Product Type
- Australian Market Overview by Technology
- Australian Market Overview by Application
- India
- Indian Market Overview by Product Type
- Indian Market Overview by Technology
- Indian Market Overview by Application
- Rest of Asia-Pacific
- Rest of Asia-Pacific Market Overview by Product Type
- Rest of Asia-Pacific Market Overview by Technology
- Rest of Asia-Pacific Market Overview by Application
9. REST OF WORLD
- Rest of World Synthetic Biology Market Overview by Geographic Region
- Rest of World Synthetic Biology Market Overview by Product Type
- Rest of World Synthetic Biology Market Overview by Technology
- Rest of World Synthetic Biology Market Overview by Application
- Country-wise Analysis of Rest of World Synthetic Biology Market
- Brazil
- Brazilian Market Overview by Product Type
- Brazilian Market Overview by Technology
- Brazilian Market Overview by Application
- Israel
- Israeli Market Overview by Product Type
- Israeli Market Overview by Technology
- Israeli Market Overview by Application
- Other Rest of World
- Other ROW Market Overview by Product Type
- Other ROW Market Overview by Technology
- Other ROW Market Overview by Application
PART C: GUIDE TO THE INDUSTRY
- NORTH AMERICA
- EUROPE
- ASIA-PACIFIC
- REST OF WORLD
PART D: ANNEXURE
- RESEARCH METHODOLOGY
- FEEDBACK
Amyris, Inc.
ATUM
Centrient Pharmaceuticals
Chevron (Renewable Energy Group, Inc.)
Codexis, Inc.
EvoNext Holdings SA
GENEWIZ, Inc
Genscript Corporation
Ginkgo Bioworks, Inc.
Green Biologics Ltd.
Integrated DNA Technologies, Inc.
International Flavors & Fragrances (IFF)
LC Sciences LLC
Millipore Sigma
Novonesis Group
Precigen, Inc.
Theriva Biologics, Inc.
Thermo Fisher Scientific, Inc.
RELATED REPORTS
Biophotonics - A Global Market Overview
Report Code: BTG017 | Pages: 465 | Price: $4950
Published
Jul 2026
Medical Laser Technologies - A Global Market Overview
Report Code: BTG047 | Pages: 291 | Price: $4500
Published
Jul 2026
Biometrics – A Global Market Overview
Report Code: BTG015 | Pages: 354 | Price: $4500
Published
Apr 2025
Global Metabolomics Market – Technologies and Applications
Report Code: BTG004 | Pages: 245 | Price: $4500
Published
Apr 2025
Bioinformatics – A Global Market Overview
Report Code: BTG005 | Pages: 223 | Price: $4500
Published
Apr 2025